Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

As devotees take a holy dip at Mahakumbh, the Yogi government has taken significant steps to safeguard their health.

AEMD READ THE FULL AEMD RESEARCH REPORT Patient treatments begin in AEMD’s basket oncology trial, enrollments expected to accelerate Aethlon Medical (NASDAQ:AEMD) reported FY 3Q results yesterday and ...

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of ...

The paediatric CRRT team of Jiangsu Provincial People’s Hospital raced to Zhenjiang on 2 February hearing of the baby’s ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Some clinical trials have validated a new perspective on continuous renal replacement therapy (CRRT) in combination with oXiris haemofilter to more effectively enhance endotoxins clearance and ...

Transportation Secretary Sean Duffy — the anti-LGBTQ+ former congressman, reality TV personality, and Fox host who replaced former Transportation Secretary Pete Buttigieg — is now saying that ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

Unlike pathogen removal and other blood-purification tools, the SCD is integrated with CRRT hemofiltration systems to selectively target and transition proinflammatory monocytes to a reparative state ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with continuous renal replacement therapy (CRRT). The trial aims to enrol 200 adult ...